BRIACELL THERAPEUTICS CORP

Historical 13F Holders

Symbol
BCTX
CUSIP
107930307
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 107930307 since 12/18/2024, largest first.

Filer % of Class Filed
Citadel Advisors LLC 13G
10.0% 1/23/2026
Event 1/15/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Iroquois Capital Management, LLC 13G/A
4.99% 11/14/2025
Event 9/30/2025
CVI Investments, Inc. 13G/A
4.9% 11/7/2025
Event 9/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 19 486 k $1.58 M
2026 Q1 16 387 k $1.62 M
2025 Q4 13 9.70 k $69.2 k
2025 Q3 13 12.4 k $136 k